Editorial

Published on 17 Sep 2024

Editorial: Raising the bar: advancing therapeutic strategies for fighting communicable and noncommunicable diseases

in Pharmacology of Infectious Diseases

Dariel Wilbert Tanoto
Jia Wen Lee
Yee Kien Chong
Rafidah Lani
Pouya Hassandarvish
Adrian Oo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486889

421 views

Original Research

Published on 13 Sep 2024

Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis

in Pharmacology of Infectious Diseases

Joscha Borho
Merle Kögel
Amelie Eckert
Holger Barth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1455696

761 views

Correction

Published on 03 Sep 2024

Corrigendum: Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Mohammad Hosseini Hooshiar
Mohammad Sholeh
Masoumeh Beig
Khalil Azizian
Ebrahim Kouhsari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465628

619 views

Original Research

Published on 02 Sep 2024

A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors

in Pharmacology of Infectious Diseases

Ajay Manaithiya
Ratul Bhowmik
Kunal Bhattacharya
Rajarshi Ray
Sagar Singh Shyamal
Fabrizio Carta
Claudiu T. Supuran
Seppo Parkkila
Ashok Aspatwar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457012

1,287 views

Systematic Review

Published on 22 Aug 2024

Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis

in Pharmacology of Infectious Diseases

Jian-Xin Peng
Ling-Zhi Wang
Qiu-Ting Wang
Hui-Long Li
Li-Jun Lin
Jun-Ming He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393861

1,103 views

Original Research

Published on 19 Aug 2024

Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study

in Pharmacology of Infectious Diseases

Ye Qiu
Hao Wen
Haoru Wang
Wenjun Sun
Guangchao Li
Shaoqiang Li
Yan Wang
Jingnan Zhai
Yangqing Zhan
Yutian Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401658

1,865 views

Review

Published on 16 Aug 2024

Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review

in Pharmacology of Infectious Diseases

Wubetu Yihunie Belay
Melese Getachew
Bantayehu Addis Tegegne
Zigale Hibstu Teffera
Abebe Dagne
Tirsit Ketsela Zeleke
Rahel Belete Abebe
Abebaw Abie Gedif
Abebe Fenta
Getasew Yirdaw

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444781

3,525 views

Review

Published on 09 Aug 2024

Plant-based nanoparticles targeting malaria management

in Pharmacology of Infectious Diseases

Pathy B. Lokole
Galilée G. Byamungu
Paulin K. Mutwale
Nadège K. Ngombe
Celestin N. Mudogo
Rui W. M. Krause
Christian I. Nkanga

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440116

2,477 views

Original Research

Published on 08 Aug 2024

Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids

in Pharmacology of Infectious Diseases

Marie-Christin Jäger
Víctor González-Ruiz
Friedrich L. Joos
Denise V. Winter
Julien Boccard
Thorsten Degenhardt
Steve Brand
Serge Rudaz
George R. Thompson
Alex Odermatt

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394846

1,215 views

Original Research

Published on 06 Aug 2024

The effect of the antibiotic stewardship program (ASP) on community-acquired pneumonia (CAP): a before–after study

in Pharmacology of Infectious Diseases

Adina Fésüs
Phiona Baluku
Éva Sipos
Sándor Somodi
Enikő Berczi-Kun
István Lekli
Ildikó Bácskay
Ria Benkő
Attila Vaskó

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406960

957 views

Original Research

Published on 02 Aug 2024

Design, synthesis and structure-activity relationship (SAR) studies of an unusual class of non-cationic fatty amine-tripeptide conjugates as novel synthetic antimicrobial agents

in Pharmacology of Infectious Diseases

Noelia Hernández-Ortiz
Pedro A. Sánchez-Murcia
Celia Gil-Campillo
Mirian Domenech
Daniel Lucena-Agell
Rafael Hortigüela
Sonsoles Velázquez
María José Camarasa
Noemí Bustamante
Sonia de Castro

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428409

1,144 views

Original Research

Published on 01 Aug 2024

Interaction of Acinetobacter sp. RIT 592 induces the production of broad-spectrum antibiotics in Exiguobacterium sp. RIT 594

in Pharmacology of Infectious Diseases

Anutthaman Parthasarathy
Renata Rezende Miranda
T. J. Bedore
Lizabeth M. Watts
Pavan K. Mantravadi
Narayan H. Wong
Jonathan Chu
Joseph A. Adjei
Amisha P. Rana
Michael A. Savka

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456027

1,206 views

Original Research

Published on 01 Aug 2024

The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity

in Pharmacology of Infectious Diseases

Yixuan Wang
Zhe Xu
Xue Xu
Shuwen Yang
Yuanyuan Li
Hanwen Zhang
Yufeng Zhang
Fu-Sheng Wang
Ying Wang
Jingfeng Bi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1421516

628 views

Original Research

Published on 31 Jul 2024

Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients

in Pharmacology of Infectious Diseases

Di Li
Qimei Fang
Zhiwei Chen
Jing Tang
Haoling Tang
Nan Cai
Ke Qiu
Mingyang Zhu
Xuemei Yang
Lu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381830

1,185 views

Original Research

Published on 29 Jul 2024

Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in Mycobacterium tuberculosis: A computational approach

in Pharmacology of Infectious Diseases

Mandeep Chouhan
Prashant Kumar Tiwari
Richa Mishra
Saurabh Gupta
Mukesh Kumar
Eman Abdullah Almuqri
Nasir A. Ibrahim
Nosiba Suliman Basher
Anis Ahmad Chaudhary
Vivek Dhar Dwivedi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403900

1,117 views

Original Research

Published on 23 Jul 2024

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury

in Pharmacology of Infectious Diseases

Quanxian Liu
Lu Huang
Hong Yan
Zhaojing Zong
Zhenyong Chen
Xiaoyan Wu
Ling Chen
Yuanbo Lan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406454

873 views

Navigation group

Articles

Editorial: Raising the bar: advancing therapeutic strategies for fighting communicable and noncommunicable diseases

Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis

Corrigendum: Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis

A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors

Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis

Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study

Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review

Plant-based nanoparticles targeting malaria management

Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids

The effect of the antibiotic stewardship program (ASP) on community-acquired pneumonia (CAP): a before–after study

Design, synthesis and structure-activity relationship (SAR) studies of an unusual class of non-cationic fatty amine-tripeptide conjugates as novel synthetic antimicrobial agents

Interaction of Acinetobacter sp. RIT 592 induces the production of broad-spectrum antibiotics in Exiguobacterium sp. RIT 594

The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity

Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients

Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in Mycobacterium tuberculosis: A computational approach

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury